fibnib

Introduction to fibnib

Fibnib is a medication available in tablet form primarily used to treat certain lung conditions. Fibnib is specifically designed to manage fibrosis pulmonary idiopathic and interstitial lung disease associated with systemic sclerosis, helping to alleviate breathing difficulties and reduce lung scarring.

Composition of fibnib

Fibnib contains the active ingredient Nintedanib, which functions as a tyrosine kinase inhibitor. This component plays a crucial role in slowing down the progression of lung diseases by targeting enzymes involved in cell growth and proliferation.

Uses of fibnib

• Treatment of idiopathic pulmonary fibrosis
• Management of interstitial lung disease associated with systemic sclerosis

Side effects of fibnib

• Common side effects: Diarrhea, nausea, vomiting
• Serious side effects: Liver problems, increased risk of bleeding

Precautions of fibnib

Regular liver function tests are necessary while on fibnib due to potential liver issues. Patients should be cautious of increased bleeding risk, especially if taking anticoagulants. Fibnib is contraindicated in individuals with severe liver impairment and those allergic to its ingredients.

How to Take fibnib

Fibnib is typically taken as a tablet, with the usual adult dose being 150 mg twice daily with food. It is crucial to follow your doctor's specific instructions regarding dosage and not to discontinue use without medical advice.

Conclusion of fibnib

Fibnib, containing Nintedanib, belongs to the therapeutic class of tyrosine kinase inhibitors. It is manufactured to treat idiopathic pulmonary fibrosis and interstitial lung disease associated with systemic sclerosis. Key highlights include its role in reducing lung scarring and improving respiratory function. For optimal results, adhere to prescribed dosages and consult your healthcare provider for any concerns.